تجاوز إلى المحتوى الرئيسي
drug protocol number
COMB157G23101
drug sponsor
Novartis
drug study
Ofatumumab
drug trial site
King Faisal Specialist Hospital and Research Center (Jeddah)
drug status
Ongoing
drug phase